Managing atopic dermatitis in canine patients

This episode is sponsored by Elanco Animal Health

During a live recording of The Vet Blast Podcast presented by dvm360 at dvm360's Fetch Kansas City conference Joya Griffin, DVM, DACVD, joined our host Adam Christman, DVM, MBA, talk more about atopic dermatitis in canine patients. Through the episode, Griffin and Christman talk about treatment options and approaches veterinary professionals can use to treat these patients, how crucial diagnostic workshops are, and the crucial role general practitioners can play in retaining relationships with clients of itchy pets.

Below is a partial transcript, edited lightly for clarity.

Adam Christman, DVM, MBA: Let's talk a little bit more about Zenrelia. So it's been on the market for nearly a year. September 2024, approval. What's your experience been with it?

Joya Griffin, DVM, DACVD: For me, more is more, of course. As a dermatologist, I see the worst cases, but it has a nice place in adding an additional option for these cases, because we know that there are patients that don't respond to one particular therapy, and we need more options.

Atopy is not a, you know, cookie-cutter type of disease, and so having another option for my patients is amazing, and I've seen some really good success in controlling these refractory dogs that haven't responded to anything else.

Christman: Excellent. And let's talk a little bit about patient selections. What types of patients would be good candidates for Zenrelia or to administer it?

Griffin: Well, Zenrelia, or ilunocitinib, is labeled for use in adult dogs 12 months or older that are presenting for pruritis related to allergic dermatitis, which can be contact allergy, food, hypersensitivity, atopic dermatitis, of course, and even flea allergies. So any of those pruritic diseases that present, even on an acute basis, you can use Zenrelia and to provide relief and itch and inflammation control.
Christman: And in the time that it's been out on the market, just overall... as a dermatologist, are you getting that relief as a dermatologist, finally [seeming] like, oh my gosh, its patients [are] responding well to it?